PARSIPPANY, N.J.--(BUSINESS WIRE)--Jan. 8, 2015--
Pacira
Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that it has
scheduled an Analyst & Investor Day on Thursday, Jan. 22, 2015, from
approximately 4:00 to 6:30 p.m. ET in New York. Members of the Pacira
management team, along with clinical experts, will provide an overview
of the Company’s future expansion plans for additional EXPAREL®
indications, as well as the leading DepoFoam®-based product candidates.
A live audio webcast of the Analyst & Investor Day will be made
accessible by visiting the “Investors & Media” section of the company’s
website at investor.pacira.com.
A replay of the webcast will be archived on the Pacira website for two
weeks following the event.
About Pacira
Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) is a specialty
pharmaceutical company focused on the clinical and commercial
development of new products that meet the needs of acute care
practitioners and their patients. The company’s current emphasis is the
development of non-opioid products for postsurgical pain control, and
its lead product, EXPAREL® (bupivacaine liposome injectable suspension),
was commercially launched in the United States in April 2012. EXPAREL
and two other products have utilized the Pacira proprietary product
delivery technology DepoFoam®, a unique platform that encapsulates drugs
without altering their molecular structure and then releases them over a
desired period of time. Additional information about Pacira is available
at www.pacira.com.
Source: Pacira Pharmaceuticals, Inc.
Pacira Pharmaceuticals, Inc.
Jessica Cho, 973-254-3574
